Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12–15 months: A phase III,randomized, non-inferiority trial 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12–15 months: A phase III,randomized, non-inferiority trial

摘要：
收稿时间：	2018-02-21
本文献已被 ScienceDirect 等数据库收录！